Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Sanofi-Aventis Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

Sarilumab

Brand Name : KEVZARA

Patent Number : 2652976

Filing Date : 2007-06-01

Strength per Unit : 150 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

Sarilumab

Brand Name : KEVZARA

Patent Number : 2652976

Filing Date : 2007-06-01

Strength per Unit : 200 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

Sanofi Company Banner

03

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2790197

Filing Date : 2011-01-07

Strength per Unit : 150 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-07

Date Granted : 2017-12-12

blank

04

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2790197

Filing Date : 2011-01-07

Strength per Unit : 200 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-07

Date Granted : 2017-12-12

blank

05

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2652976

Filing Date : 2007-06-01

Strength per Unit : 150 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

blank

06

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2790197

Filing Date : 2011-01-07

Strength per Unit : 150 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-07

Date Granted : 2017-12-12

blank

07

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2652976

Filing Date : 2007-06-01

Strength per Unit : 200 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-06-01

Date Granted : 2015-08-11

blank

08

Sanofi-Aventis Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Sanofi-Aventis Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Sarilumab

Brand Name : KEVZARA

Patent Number : 2790197

Filing Date : 2011-01-07

Strength per Unit : 200 mg / 1.14 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-01-07

Date Granted : 2017-12-12

blank